Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

WeDoctor drops Credit Suisse from $1 billion IPO role over Luckin probe - sources

Published 06/04/2020, 12:01
Updated 06/04/2020, 12:05
© Reuters. Men wearing shirts bearing the logo of online healthcare solutions platform WeDoctor attend a signing ceremony in Zhengzhou

© Reuters. Men wearing shirts bearing the logo of online healthcare solutions platform WeDoctor attend a signing ceremony in Zhengzhou

By Julie Zhu and Kane Wu

HONG KONG (Reuters) - Chinese online healthcare platform WeDoctor has dropped Credit Suisse (S:CSGN) from a list of banks it had lined up lead its up to $1 billion initial public offering in Hong Kong, two people of direct knowledge told Reuters.

WeDoctor's decision comes days after China's securities regulator said it would investigate claims of fraud at coffee startup Luckin Coffee (O:LK) where an internal investigation had found that its chief operating officer and other staff fabricated sales transactions worth about 2.2 billion yuan.

Credit Suisse, together with Morgan Stanley (N:MS), CICC (HK:3908) and Haitong International Securities (HK:0665), worked on Luckin Coffee's $645 million U.S. IPO in May last year.

"WeDoctor's executives have concerns over Credit Suisse's role in Luckin-related deals. Given uncertainty over the outcome, the bank is probably no longer suitable to work on WeDoctor's IPO," said one of the people, who declined to be named as the information is confidential.

Credit Suisse declined to comment.

WeDoctor said: "WeDoctor is scrupulous in our consideration of partners. A selection of sponsors is underway and a final decision has not been made." WeDoctor declined to comment further on its IPO plans.

CICC and Morgan Stanley have begun informal investigations into the due diligence they did for the Luckin IPO since the Chinese coffee chain's announcement on Thursday, Reuters reported last week, citing sources. These two banks, Haitong and Credit Suisse had declined to comment last week.

WeDoctor, which is backed by Tencent Holdings Ltd (HK:0700) and Goldman Sachs (N:GS), in March mandated Credit Suisse, JPMorgan (N:JPM) and China Merchants Bank International for its float, which could value the company at up to $10 billion.

© Reuters. Men wearing shirts bearing the logo of online healthcare solutions platform WeDoctor attend a signing ceremony in Zhengzhou

The company is now looking for a replacement for Credit Suisse, said the people.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.